Pronutria Biosciences Lands $42,500,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=79425500-1afd-49c2-9969-bd016cf76f72 - Date
2/24/2016 - Company Name
Pronutria Biosciences - Mailing Address
840 Memorial Drive 3rd Floor Cambridge, MA 02139 USA - Company Description
Pronutria is pioneering first-in-class medicines to treat or cure serious conditions where cell homeostasis has been disrupted by amino acid imbalances. We achieve this by using a systems pharmacology approach to deliver disease-specific amino acid compositions that improve the function of biological pathways and regenerate health. - Website
http://www.pronutriabio.com - Transaction Type
Venture Equity - Transaction Amount
$42,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
The proceeds from this financing will help to fund the ongoing rapid transformation of the company from a unique and revolutionary platform to late stage clinical candidates in several disease indications. - M&A Terms
- Venture Investor
Nestlé Health Science
